رجوع
نطاق اليوم
KWD 32.02
KWD 33.50
نطاق 52 أسبوعًا
KWD 29.24
KWD 48.75
حجم التداول
547,905
متوسط 50 يوم / 200 يوم
KWD 35.89
/
KWD 36.82
الإغلاق السابق
KWD 32.45
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 101.7 | 0.4 |
| P/B | 4.7 | 2.9 |
| ROE % | 5.1 | 3.9 |
| Net Margin % | 6.0 | 3.8 |
| Rev Growth 5Y % | 15.3 | 10.0 |
| D/E | 0.3 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 45.500
+37.5%
Low: KWD 45.000
High: KWD 46.000
مكرر الربحية المستقبلي
75.0
ربحية السهم المستقبلية
KWD 0.433
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
320 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 2.090
KWD 2.067 – KWD 2.118
|
650 M | 2 |
| FY2029 |
KWD 1.650
KWD 1.632 – KWD 1.672
|
510 M | 2 |
| FY2028 |
KWD 1.295
KWD 1.070 – KWD 1.520
|
440 M | 4 |
النقاط الرئيسية
Revenue grew 15.32% annually over 5 years — strong growth
Earnings grew 59.41% over the past year
Debt/Equity of 0.28 — conservative balance sheet
Generating 24.75M in free cash flow
P/E of 101.66 — premium valuation
Cash machine — converts 149.82% of earnings into free cash flow
النمو
Revenue Growth (5Y)
15.32%
Revenue (1Y)16.45%
Earnings (1Y)59.41%
FCF Growth (3Y)78.15%
الجودة
Return on Equity
5.11%
ROIC1.83%
Net Margin5.98%
Op. Margin4.00%
الأمان
Debt / Equity
0.28
Current Ratio5.03
Interest Coverage7.10
التقييم
P/E Ratio
101.66
P/B Ratio4.74
EV/EBITDA151.89
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 16.45% | Revenue Growth (3Y) | 18.27% |
| Earnings Growth (1Y) | 59.41% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 15.32% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 276.26M | Net Income (TTM) | 16.52M |
| ROE | 5.11% | ROA | 3.39% |
| Gross Margin | 74.42% | Operating Margin | 4.00% |
| Net Margin | 5.98% | Free Cash Flow (TTM) | 24.75M |
| ROIC | 1.83% | FCF Growth (3Y) | 78.15% |
| Safety | |||
| Debt / Equity | 0.28 | Current Ratio | 5.03 |
| Interest Coverage | 7.10 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 101.66 | P/B Ratio | 4.74 |
| P/S Ratio | 6.08 | PEG Ratio | 1.93 |
| EV/EBITDA | 151.89 | Dividend Yield | 0.00% |
| Market Cap | 1.68B | Enterprise Value | 1.68B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 276.26M | 237.22M | 197.52M | 164.37M | 156.18M |
| Net Income | 16.52M | 10.36M | -3.18M | -16.71M | -7.47M |
| EPS (Diluted) | 0.32 | 0.20 | -0.07 | -0.35 | -0.16 |
| Gross Profit | 205.60M | 172.11M | 135.58M | 109.79M | 106.03M |
| Operating Income | 11.04M | 4.52M | -6.46M | -17.06M | -7.85M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 487.97M | 432.72M | 353.66M | 273.00M | 243.71M |
| Total Liabilities | 133.33M | 140.76M | 127.71M | 80.73M | 73.24M |
| Shareholders' Equity | 354.64M | 291.97M | 225.95M | 192.27M | 170.46M |
| Total Debt | 98.27M | 98.85M | 88.04M | 47.57M | 50.18M |
| Cash & Equivalents | 100.09M | 74.52M | 69.09M | 51.07M | 68.33M |
| Current Assets | 247.44M | 212.78M | 205.63M | 186.87M | 158.46M |
| Current Liabilities | 49.15M | 50.29M | 45.75M | 37.46M | 26.05M |